Finanical Statements
Macro Group Pharmaceuticals -Macro Capital (MCRO.CA) Reports 3 Months Standalone Results
Published at 17 May 2026 at 14:49Related stock: MCRO
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Macro Group Pharmaceuticals -Macro Capital
ISIN Code : EGS7D971C011
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 31/03/2026
Net Profit : 33,617,267
F/S Standalone Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 24,457,145
Audit Status : Reviewed
Source : Macro Group Pharmaceuticals -Macro Capita
The Financial Statements in Arabic (2,504 KB)
The Financial Statements in English (3,297 KB)
ISIN Code : EGS7D971C011
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 31/03/2026
Net Profit : 33,617,267
F/S Standalone Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 24,457,145
Audit Status : Reviewed
Source : Macro Group Pharmaceuticals -Macro Capita
The Financial Statements in Arabic (2,504 KB)
The Financial Statements in English (3,297 KB)